In a study conducted by Macciò et al. (2009), the serum levels of leptin were significantly lower in patients with stage III/IV ovarian cancer (n=75) in comparison with controls (n= 95) and patients with stage I/II disease (n=29). Here, LEP is linked to ovarian cancer.